You just read:

Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of Patients with Locally Advanced, Unresectable or Metastatic GIST

News provided by

Bayer HealthCare Pharmaceuticals Inc.

Feb 25, 2013, 16:05 ET